• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与糖尿病患者复发性和对侧夏科氏神经关节病发展相关的因素:范围综述。

Factors associated with the development of recurrent and contralateral Charcot neuroarthropathy in individuals with diabetes mellitus: A scoping review.

机构信息

Discipline of Podiatry, School of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Victoria, Australia.

La Trobe Rural Health School, La Trobe University, Bendigo, Victoria, Australia.

出版信息

J Foot Ankle Res. 2024 Dec;17(4):e70016. doi: 10.1002/jfa2.70016.

DOI:10.1002/jfa2.70016
PMID:39550635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11569389/
Abstract

INTRODUCTION

Charcot neuroarthropathy (CN) can result in fractures and dislocations of the foot and ankle in individuals with diabetes and neuropathy, leading to ulceration, amputation and a poor quality of life. Additional episodes of acute CN can lead to extended periods of physical and psychosocial distress. The aim of this scoping review was to identify and synthesise the evidence relating to factors associated with the development of recurrent and contralateral Charcot neuroarthropathy (CN) in individuals with diabetes.

METHODS

A systematic search of four electronic databases was conducted from inception to February 06, 2023. All relevant study designs, except single case studies, that had been published in full in peer-reviewed journals were included. Studies were excluded if they were not published in English and did not provide data on individuals with diabetes.

RESULTS

The search identified two studies that investigated factors associated with the development of recurrent CN, but none that related to the development of contralateral CN. Ten factors were investigated for association with recurrent CN development: age, body mass index, diabetes type and duration, glycated haemoglobin, anatomical site affected, duration of offloading applied to treat the primary CN episode, use of pharmacological intervention, severity of neuropathy, and skin temperature. However, no significant associations were reported.

CONCLUSIONS

There is an alarming lack of evidence-based findings in this research area to guide practice. Clearly, more research in the form of rigorous prospective studies is urgently required to identify risk factors for the development of recurrent and contralateral CN in individuals with diabetes.

摘要

简介

夏科氏关节病(CN)可导致糖尿病和神经病变患者足部和踝关节骨折和脱位,导致溃疡、截肢和生活质量下降。CN 的急性发作次数增加会导致身体和社会心理困扰的延长。本综述的目的是确定和综合与糖尿病患者复发性和对侧夏科氏神经关节病(CN)发展相关的因素的证据。

方法

从成立到 2023 年 2 月 6 日,对四个电子数据库进行了系统搜索。所有相关的研究设计,除了单一病例研究,只要已在同行评审期刊上全文发表,都包括在内。如果研究不是用英文发表的,并且没有提供有关糖尿病患者的数据,则将其排除在外。

结果

搜索确定了两项研究调查了与复发性 CN 发展相关的因素,但没有一项与对侧 CN 发展相关。有 10 个因素被调查与复发性 CN 发展相关:年龄、体重指数、糖尿病类型和持续时间、糖化血红蛋白、受影响的解剖部位、用于治疗原发性 CN 发作的减压时间、药物干预的使用、神经病变的严重程度和皮肤温度。然而,没有报告显著的相关性。

结论

在这个研究领域,令人震惊的是缺乏循证发现来指导实践。显然,迫切需要更严格的前瞻性研究来确定糖尿病患者复发性和对侧 CN 发展的风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaa/11569389/c80c68dc3005/JFA2-17-e70016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaa/11569389/c80c68dc3005/JFA2-17-e70016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaa/11569389/c80c68dc3005/JFA2-17-e70016-g001.jpg

相似文献

1
Factors associated with the development of recurrent and contralateral Charcot neuroarthropathy in individuals with diabetes mellitus: A scoping review.与糖尿病患者复发性和对侧夏科氏神经关节病发展相关的因素:范围综述。
J Foot Ankle Res. 2024 Dec;17(4):e70016. doi: 10.1002/jfa2.70016.
2
Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.2型糖尿病患者发生夏科氏关节病的危险因素。
Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):31-4. doi: 10.1055/s-0033-1358483. Epub 2013 Nov 7.
3
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.2型糖尿病患者夏科氏神经关节病中针对翻译后修饰的I型和II型胶原蛋白的自身抗体。
Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2839. Epub 2016 Oct 5.
4
Recurrence of the acute Charcot foot in diabetes.糖尿病性急性夏科足的复发。
Diabet Med. 2012 Jun;29(6):819-21. doi: 10.1111/j.1464-5491.2011.03539.x.
5
Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review.糖尿病患者伴骨髓炎的中足夏科氏神经关节病的手术治疗:系统评价。
J Wound Care. 2020 Jun 1;29(Sup6):S19-S28. doi: 10.12968/jowc.2020.29.Sup6.S19.
6
[Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].[代偿期糖尿病患者夏科氏关节病的早期发展——病例报告]
Pol Arch Med Wewn. 2004 Jun;111(6):709-13.
7
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.糖尿病性活跃性夏科氏神经关节病中炎症和破骨细胞生成的差异缓解对足部长期结局的影响。
PLoS One. 2021 Nov 8;16(11):e0259224. doi: 10.1371/journal.pone.0259224. eCollection 2021.
8
Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.糖尿病性神经病变性关节病(夏科氏关节病)采用骨科器械进行保护性完全负重治疗后的结果:单侧和双侧受累患者的比较
BMC Musculoskelet Disord. 2016 Dec 29;17(1):504. doi: 10.1186/s12891-016-1357-4.
9
Diabetes Mellitus: An Overview in Relationship to Charcot Neuroarthropathy.糖尿病:与夏科氏神经关节病的关系概述。
Clin Podiatr Med Surg. 2022 Oct;39(4):535-542. doi: 10.1016/j.cpm.2022.05.001. Epub 2022 Aug 6.
10
Midterm Fate of the Contralateral Foot in Charcot Arthropathy.夏科氏关节病对侧足部的中期转归。
Foot Ankle Int. 2020 Oct;41(10):1181-1189. doi: 10.1177/1071100720937654. Epub 2020 Jul 22.

引用本文的文献

1
Management of hindfoot and ankle in Charcot arthropathy.夏科氏关节病中后足和踝关节的管理
EFORT Open Rev. 2025 Jun 2;10(6):327-335. doi: 10.1530/EOR-2025-0057.

本文引用的文献

1
Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023).《糖尿病相关活跃性夏科氏骨-神经病的诊断和治疗指南(IWGDF 2023)》。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3646. doi: 10.1002/dmrr.3646. Epub 2023 May 23.
2
A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM).一项随机可行性研究表明,对于糖尿病性夏科氏神经骨关节病(CADOM)患者,多次磁共振成像有助于减少治疗时间。
J Foot Ankle Res. 2023 Jan 26;16(1):2. doi: 10.1186/s13047-023-00601-7.
3
A qualitative study to understand people's experiences of living with Charcot neuroarthropathy.
一项定性研究,旨在了解人们患有夏科氏神经关节病的生活体验。
Diabet Med. 2022 Jun;39(6):e14784. doi: 10.1111/dme.14784. Epub 2022 Jan 14.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
Are the Sanders-Frykberg and Brodsky-Trepman Classifications Reliable in Diabetic Charcot Neuroarthropathy?糖尿病性夏科氏神经关节病的桑德斯-弗赖伯格分类和布罗德斯基-特雷普曼分类可靠吗?
J Foot Ankle Surg. 2021 May-Jun;60(3):432-435. doi: 10.1053/j.jfas.2020.03.003. Epub 2021 Feb 3.
6
How Common Is the Rare Charcot Foot in Patients With Diabetes?糖尿病患者中罕见的夏科氏足有多常见?
Diabetes Care. 2021 Apr;44(4):e62-e63. doi: 10.2337/dc20-2590. Epub 2021 Feb 1.
7
Midterm Fate of the Contralateral Foot in Charcot Arthropathy.夏科氏关节病对侧足部的中期转归。
Foot Ankle Int. 2020 Oct;41(10):1181-1189. doi: 10.1177/1071100720937654. Epub 2020 Jul 22.
8
Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.糖尿病足并发症患者的 5 年死亡率和医疗费用直接堪比癌症。
J Foot Ankle Res. 2020 Mar 24;13(1):16. doi: 10.1186/s13047-020-00383-2.
9
Mortality and complications after treatment of acute diabetic Charcot foot.急性糖尿病性夏科足治疗后的死亡率和并发症。
J Diabetes Complications. 2018 Dec;32(12):1141-1147. doi: 10.1016/j.jdiacomp.2018.09.013. Epub 2018 Sep 29.
10
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.